Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urinary Tract Infection II: Pathophysiology

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

Microbiota of the Urogenital Tract

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...

Urine Studies II: Urine Culture and Sensitivity Test

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

Urinary Tract Infection I: Introduction

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and validation of PEYRO-Q: a novel multidimensional patient-reported outcome measure for Peyronie's disease.

Sexual medicine·2026

Same author

Optimizing urology residency education in Italy: a national tele-lecture experience.

Minerva urology and nephrology·2026

Same author

TOP Flat Magnetic Stimulation therapy for post-prostatectomy stress urinary incontinence.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026

Same author

Flat magnetic stimulation technology: a promising therapy for erectile dysfunction management.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026

Same author

Effectiveness of hyaluronic acid in the treatment of Peyronie's disease in the light of the European Urology Guidelines: the real-world experience.

Minerva urology and nephrology·2025

Same author

Teupolioside and Graminex (Xipag®) combined therapy induced anti-inflammatory effects and decreased dihydrotestosterone levels in the prostate tissue of patients with benign prostate hyperplasia: results of a pilot study.

Minerva urology and nephrology·2025

Search research articles

Related Experiment Video

Updated: May 31, 2026

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

Tommaso Cai¹, Sandra Mazzoli, Francesca Meacci

¹Department of Urology, Santa Chiara Hospital, Trento, 38123, Italy. ktommy@libero.it

Journal of Microbiology (Seoul, Korea)

|July 1, 2011

Summary

This study tracked pathogens in chronic bacterial prostatitis (CBP) patients over ten years. It found increasing Gram-positive bacteria and decreasing susceptibility to ciprofloxacin, with levofloxacin remaining effective.

More Related Videos

Mouse Models of Epididymitis Induced by Pathogen-Associated Molecular Patterns

Mouse Models of Epididymitis Induced by Pathogen-Associated Molecular Patterns

Published on: December 12, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Related Experiment Videos

Last Updated: May 31, 2026

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

Mouse Models of Epididymitis Induced by Pathogen-Associated Molecular Patterns

Mouse Models of Epididymitis Induced by Pathogen-Associated Molecular Patterns

Published on: December 12, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Area of Science:

Urology
Infectious Diseases
Microbiology

Background:

Chronic bacterial prostatitis (CBP) is typically caused by Gram-negative bacilli, but Gram-positive and atypical microorganisms are increasingly reported.
Understanding pathogen prevalence and antimicrobial resistance is crucial for effective CBP management.

Purpose of the Study:

To analyze the epidemiological trends and antimicrobial resistance patterns of uropathogens in outpatients with CBP over a 10-year period (1997-2008).

Main Methods:

A retrospective analysis of microbiological data from 6,221 CBP outpatients.
Uropathogens were isolated from urine and prostatic secretions.
Prevalence and resistance rates were analyzed across four distinct time periods.

Main Results:

Enterococcus faecalis and Escherichia coli were the most frequent pathogens.
A significant increase in E. faecalis prevalence was observed, particularly in later years.
Both Gram-positive and Gram-negative strains showed decreased susceptibility to ciprofloxacin, while levofloxacin maintained good activity.

Conclusions:

The prevalence of E. faecalis in CBP has increased over the study period.
Antimicrobial resistance patterns are shifting, necessitating updated treatment guidelines.
Levofloxacin appears to be a more reliable treatment option compared to ciprofloxacin for CBP.